Coinbase CEO’s Biotech Firm Gets $130M to Fight Aging With AI, Genomics

NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.

​NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality. Health Decrypt

Leave a Reply

Your email address will not be published. Required fields are marked *